ClinConnect ClinConnect Logo
Search / Trial NCT03269578

Sample Collection and Tracking for the Developmental Therapeutics Clinic

Launched by NATIONAL CANCER INSTITUTE (NCI) · Aug 31, 2017

Trial Information

Current as of May 15, 2025

Recruiting

Keywords

Pharmacodynamics Tissue Collection Tissue Biopsies Biospecimen Assay Development Natural History

ClinConnect Summary

This clinical trial is focusing on improving how researchers understand cancer treatment by collecting and linking data from patients. If you join the Developmental Therapeutics Clinic (DTC), you will be asked to allow researchers to access your past and current medical records, as well as any research samples you have provided. This will help them see how different treatments have worked over time for patients with various types of cancer, including neoplasms and lymphoma.

To participate, you need to be at least 18 years old and currently being evaluated or treated for cancer at the DTC. You'll not need to provide any new samples for this study. Instead, the goal is to combine information from all the studies you’ve been part of, which will help improve future cancer therapies. This trial is currently recruiting participants, and there are no specific exclusions based on health conditions, so if you meet the age and treatment criteria, you could be eligible.

Gender

ALL

Eligibility criteria

  • * INCLUSION CRITERIA:
  • Patients who are being evaluated and/or treated for cancer or benign tuumors in the Developmental Therapeutics Clinic at the NIH Clinical Center
  • Ability to understand and willingness to sign a written informed consent document indicating their willingness to have data from their tissue or biologic fluid research specimens and limited medial information used for research as outlined in this protocol and to allow protocol staff access to the CRIS database and their Medical Records Number (MRN).
  • Age greater than or equal to 18 years
  • ECLUSION CRITERIA:
  • None

About National Cancer Institute (Nci)

The National Cancer Institute (NCI) is a prominent component of the National Institutes of Health (NIH), dedicated to advancing cancer research and improving patient outcomes through innovative clinical trials. As a leading sponsor of cancer-related studies, NCI focuses on facilitating the development of new therapies, enhancing prevention strategies, and understanding the biology of cancer. The institute collaborates with academic institutions, healthcare providers, and industry partners to conduct rigorous clinical trials that aim to translate scientific discoveries into effective treatments. NCI’s commitment to fostering a robust research environment supports the mission to eliminate cancer as a major health problem.

Locations

Bethesda, Maryland, United States

Patients applied

0 patients applied

Trial Officials

Alice P Chen, M.D.

Principal Investigator

National Cancer Institute (NCI)

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials